NCT01390766已完成不适用
Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 41
- 主要终点
- The number of incidence of adverse events related to azathioprine tablets and serious adverse events
研究概览
简要总结
This post-marketing surveillance (PMS) study is designed to investigate the efficacy and safety of azathioprine tablets in Japanese subjects whom liver transplantation is performed.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects who undergo liver transplantation and azathioprine tablet was administered
排除标准
- •As this is PMS study, there are no exclusion criteria but contraindications are as follows.
- •Subjects with hypersensitivity to the ingredients of azathioprine tablet
- •Subjects who is pregnant or might be pregnant
- •Subjects whose white count is lower than 3000/cubic millimeter
研究组 & 干预措施
Subjects prescribed azathioprine tablet
Subjects prescribed azathioprine tablet during study period after the liver transplantation
干预措施: Azathioprine (Drug)
结局指标
主要结局
The number of incidence of adverse events related to azathioprine tablets and serious adverse events
时间窗: 1 year
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation)Liver DiseasesNCT01381432GlaxoSmithKline39
已完成
不适用
Assessment of Compliance With Antihypertensive Telmisartan TherapyHypertensionNCT00470886Bayer3,400
已完成
不适用
The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial HypertensionHypertensionNCT00471003Bayer5,448
已完成
不适用
Drug Use Investigation for HEPSERA (Adefovir) TabletHepatitis BNCT01863589GlaxoSmithKline436
已完成
不适用
Drug Use Investigation for XYZAL®Rhinitis, Allergic, Perennial and SeasonalNCT01445262GlaxoSmithKline10,728